Advances in Chronic Kidney Disease
Volume 16, Issue 2 , Pages 76-82 , March 2009

Hyporesponsiveness to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: The Many Faces of Inflammation

  • John W. Adamson

      Affiliations

    • Corresponding Author InformationAddress correspondence to John W. Adamson, MD, Division of Hematology/Oncology, University of California at San Diego, VA Medical Center MC 111E, 3350 La Jolla Village Drive, San Diego, CA 92161.

References 

  1. Hillman RS, Finch CA. Red Cell Manual (ed 7). Philadelphia, PA: FA Davis; 1996;p 190
  2. Miller CB, Jones RJ, Piantodosi S, et al. Decreased erythropoietin response in patients with the anemia of cancer. N Eng J Med. 1990;322:1689–1692
  3. Roy CN, Mak H, Akpan I, et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007;109:4038–4044
  4. Eschbach JW, Egrie JC, Downing MR, et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987;316:73–78
  5. Lee GR. The anemia of chronic disease. Semin Hematol. 1983;20:61–80
  6. Cash JM, Sears DA. The spectrum of disease associated with the anemia of chronic disease: A study of 90 cases. Am J Med. 1990;87:638–644
  7. Means RT. Pathogenesis of the anemia of chronic disease: a cytokine mediated anemia. Stem Cells. 1995;13:32–37
  8. Weiss G, Goodnough LT. Anemia of chronic disease. Medical progress. New Eng J Med. 2005;352:1011–102314
  9. Zanjani ED, McGlave PB, Davies SF, et al. In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infections. Br J Haematol. 1982;50:479–490
  10. Roodman GD, Horadam VW, Wright TL. Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease. Blood. 1983;62:406–412
  11. Broxmeyer HE, Williams DE, Lu L, et al. The suppressive influences of tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-γ. J Immunol. 1986;136:4487–4495
  12. Means RT, Dessypris EN, Krantz SB. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol. 1992;150:59–64
  13. Means RT, Dessypris EN, Krantz SB. Inhibition of human colony-forming units erythroid by tumor necrosis factor requires accessory cells. J Clin Invest. 1990;86:538–541
  14. Means RT, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest. 1993;91:416–419
  15. Means RT, Krantz SB, Luna J, et al. Inhibition of murine erythroid colony formation in vitro by gamma interferon and correction by interferon inhibitor. Blood. 1994;83:911–915
  16. Johnson CS, Keckler DJ, Topper MI, et al. In vivo hematopoietic effects of recombinant interleukin-1α in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood. 1989;73:678–683
  17. Johnson RA, Waddelow TA, Caro J, et al. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood. 1989;74:130–138
  18. Means RT, Krantz SB. Inhibition of human erythroid colony-forming units by interferons alpha and beta: Differing mechanisms despite shared receptor. Exp Hematol. 1996;24:204–208
  19. Papadaki HA, Kritikos HD, Gemetzi C, et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: Evidence for a tumor necrosis factor alpha-mediated effect. Blood. 2002;99:1610–1619
  20. Papadaki HA, Kritikos HD, Valatas V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: Improvement following anti-tumor necrosis factor-α antibody therapy. Blood. 2002;100:474–482
  21. Dinarello CA. Cytokines: Agents provocateurs in hemodialysis?. Kidney Int. 1992;41:683–69416
  22. Goicoechea M, Martin J, de Sequera P, et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int. 1998;54:1337–1343
  23. Panichi V, Migliori M, Pietro De, et al. The link of biocompatibility to cytokine production. Kidney Int. 2000;58(Suppl 76):S96–S103
  24. Pertosa G, Grandaliano G, Gesualdo L, et al. Clinical relevance of cytokine production in hemodialysis patients. Kidney Int. 2000;58(Suppl 76):S104–S111
  25. Yokoyama H, Kawaguchi T, Wada T, et al. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in Japanese patients on chronic non-reuse hemodialysis: A prospective cohort study from the J-DOPPS II study. Nephron Clin Practice. 2008;109:100–108
  26. Nicolas G, Viatte L, Bennoun M, et al. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002;29:327–335
  27. Elin RJ, Wolff SM, Finch CA. Effect of induced fever on serum iron and ferritin concentrations in man. Blood. 1977;49:147–153
  28. Babitt JL, Huang FW, Wrighting DM, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin gene expression. Nat Genet. 2006;38:531–539
  29. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276
  30. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204–3209
  31. Peyssonnaux C, Zinkernagel S, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107:3727–3732
  32. Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111:2392–2399
  33. Pinto JP, Ribeiro S, Pontes H, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα. Blood. 2008;111:5727–5733
  34. Dallalio G, Law E, Means RT. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood. 2006;107:2702–2704
  35. Tomosugi N, Kawabata H, Wakatabe R, et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood. 2006;108:1381–1387
  36. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–4297

PII: S1548-5595(08)00216-4

doi: 10.1053/j.ackd.2008.12.009

Advances in Chronic Kidney Disease
Volume 16, Issue 2 , Pages 76-82 , March 2009

Article Tools

* Image Usage & Resolution